Clinical trial · Interventional
Mixed Reality Technique Combined With 3D Printing Navigational Template for Localizing Pulmonary Nodules
Preoperative Mixed Reality Technique Combined With Three-Dimensional Printing Navigational Template Guided Localizing Pulmonary Small Nodules : a Prospective, Unicenter, Randomized Study.
NCT04552054CI-TRIAL-00047195MR&3D LocalunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the viability and accuracy of preoperative mixed reality technique combined with three-dimensional printing navigational template guided localizing pulmonary small nodules.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Pulmonary Nodule, Multiple | — | UNRESOLVED | — |
| Pulmonary Nodule, Solitary | — | UNRESOLVED | — |
| Video-assisted Thoracic Surgery | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Computerized Tomography guided localization | Device | — | UNRESOLVED |
| Mixed Reality+ 3D printing guided localization | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- CT guided localization
- description
- Computerized Tomography(CT)-guided percutaneous lung puncture staining marker localization
- interventionNames
- Device: Computerized Tomography guided localization
- type
- EXPERIMENTAL
- label
- MR+3D guided localization
- description
- Mixed reality(MR)+3D printing-guided percutaneous lung puncture staining marker localization
- interventionNames
- Device: Mixed Reality+ 3D printing guided localization
Primary outcomes (1)
- measure
- Puncture success rate of localization
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * a maximum target lung nodule (one or more) diameter ≤20 mm * a target nodule CTR \<0·25 or a minimum distance from the outer edge of the nodule to the nearest pleural surface \>10 mm if the target nodule CTR was \>0·25. * Plan to perform VATS lung wedge resection Exclusion Criteria: * Inability to comply with research protocols or research procedures * Any unstable systemic disease (including active infections, uncontrolled high blood pressure, unstable angina, angina pectoris that has started within the last 3 months, congestive heart failure (≥ New York Heart Association \[NYHA\] Level II ), cardiac infarction (6 months before enrollment), severe arrhythmia requiring medication, liver, kidney or metabolic disease * Active bleeding; Inability to withstand lying flat; Inability to cooperate through breathing during puncture * Pregnant or lactating women * Other circumstances that the investigator believes are not suitable for enrollment
References
Publications (0)
Data not yet available
No reference posted for this study.